Experienced in Heart Failure

Olga L. Barbarash

Sosnoviy Blvd, 6, 
Kemerovo, KEM, RU 
Experienced in Heart Failure
Sosnoviy Blvd, 6, 
Kemerovo, KEM, RU 
OverviewLocationsClinical Research

Overview

Olga Barbarash practices in Kemerovo, Russian Federation. Ms. Barbarash is rated as an Experienced expert by MediFind in the treatment of Heart Failure. Her top areas of expertise are Heart Attack, Coronary Heart Disease, Atherosclerosis, Heart Bypass Surgery, and Coronary Artery Bypass Graft (CABG).

Her clinical research consists of co-authoring 279 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 26 articles and participated in 1 clinical trial in the study of Heart Failure.

Gender
Female

Locations

Sosnoviy Blvd, 6, Kemerovo, KEM 650002, Russian Federation
Other Locations
Siberian Branch, Kemerovo, KEM, Russian Federation

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized, Double-Blind, Placebo- Controlled Study to Investigate the Efficacy and Safety of Injectafer® (Ferric Carboxymaltose) as Treatment for Heart Failure With Iron Deficiency /and Sub-Study
A Randomized, Double-Blind, Placebo- Controlled Study to Investigate the Efficacy and Safety of Injectafer® (Ferric Carboxymaltose) as Treatment for Heart Failure With Iron Deficiency /and Sub-Study
Enrollment Status: Completed
Publish Date: July 03, 2024
Intervention Type: Drug
Study Drug: Ferric Carboxymaltose
Study Phase: Phase 3
An Open-label, Long Term Extension Study for Treatment of Pulmonary Arterial Hypertension in Paediatric Patients Aged 8 Years up to 18 Years Who Have Participated in AMB112529 and in Whom Continued Treatment With Ambrisentan is Desired
An Open-label, Long Term Extension Study for Treatment of Pulmonary Arterial Hypertension in Paediatric Patients Aged 8 Years up to 18 Years Who Have Participated in AMB112529 and in Whom Continued Treatment With Ambrisentan is Desired
Enrollment Status: Completed
Publish Date: December 30, 2022
Intervention Type: Drug
Study Drug: Ambrisentan
Study Phase: Phase 2
View 1 Less Clinical Trial

279 Total Publications

Continuous Intravenous Insulin Infusion in Patients with Diabetes Mellitus After Coronary Artery Bypass Grafting: Impact on Glycemic Control Parameters and Postoperative Complications.
Continuous Intravenous Insulin Infusion in Patients with Diabetes Mellitus After Coronary Artery Bypass Grafting: Impact on Glycemic Control Parameters and Postoperative Complications.
Journal: Journal of clinical medicine
Published: March 25, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Barbarash's expertise for a condition
ConditionClose
    View All 28 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile